Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Emergence of macrolide-resistant Streptococcus pyogenes strains in French children.

Literature DB >> 15328126

Emergence of macrolide-resistant Streptococcus pyogenes strains in French children.

Edouard Bingen¹, Philippe Bidet, Liliana Mihaila-Amrouche, Catherine Doit, Samuel Forcet, Naïma Brahimi, Anne Bouvet, Robert Cohen.

Abstract

We studied the antimicrobial susceptibility of 322 Streptococcus pyogenes throat isolates from French children and their serotype and genomic diversity. A total of 22.4% were erythromycin resistant, and 69.4, 4.2, and 26.4% of these isolates harbored ermB, ermA, and mefA, respectively. Increasing resistance in France is mainly associated with a few emm type 28 clones.

Entities: Chemical Species

Mesh：

Substances：

Year: 2004 PMID： 15328126 PMCID： PMC514735 DOI： 10.1128/AAC.48.9.3559-3562.2004

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

18 in total

1. Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada.

Authors: J C De Azavedo; R H Yeung; D J Bast; C L Duncan; S B Borgia; D E Low
Journal: Antimicrob Agents Chemother Date: 1999-09 Impact factor: 5.191

2. Dissemination of emm28 erythromycin-, clindamycin- and bacitracin-resistant Streptococcus pyogenes in Spain.

Authors: E Perez-Trallero; C Garcia; B Orden; J M Marimon; M Montes
Journal: Eur J Clin Microbiol Infect Dis Date: 2004-01-08 Impact factor: 3.267

3. Phenotypic and genotypic characterization of macrolide-resistant group A Streptococcus strains in the province of Quebec, Canada.

Authors: K Weiss; J De Azavedo; C Restieri; L A Galarneau; M Gourdeau; P Harvey; J F Paradis; K Salim; D E Low
Journal: J Antimicrob Chemother Date: 2001-03 Impact factor: 5.790

4. Emergence of group A streptococcus strains with different mechanisms of macrolide resistance.

Authors: Edouard Bingen; Roland Leclercq; Frédéric Fitoussi; Naïma Brahimi; Brigitte Malbruny; Dominique Deforche; Robert Cohen
Journal: Antimicrob Agents Chemother Date: 2002-05 Impact factor: 5.191

5. In vitro activity of midecamycin diacetate, a 16-membered macrolide, against Streptococcus pyogenes isolated in France, 1995-1999.

Authors: L Schlegel; B Merad; H Rostane; V Broc; A Bouvet
Journal: Clin Microbiol Infect Date: 2001-07 Impact factor: 8.067

6. Erythromycin-resistant group A streptococci in schoolchildren in Pittsburgh.

Authors: Judith M Martin; Michael Green; Karen A Barbadora; Ellen R Wald
Journal: N Engl J Med Date: 2002-04-18 Impact factor: 91.245

7. Antimicrobial resistance amongst isolates of Streptococcus pyogenes and Staphylococcus aureus in the PROTEKT antimicrobial surveillance programme during 1999-2000.

Authors: Rafael Cantón; Elena Loza; M Isabel Morosini; Fernando Baquero
Journal: J Antimicrob Chemother Date: 2002-09 Impact factor: 5.790

8. Activity of telithromycin compared with seven other agents against 1039 Streptococcus pyogenes pediatric isolates from ten centers in central and eastern Europe.

Authors: B Bozdogan; P C Appelbaum; L M Kelly; D B Hoellman; A Tambic-Andrasevic; L Drukalska; W Hryniewicz; H Hupkova; M R Jacobs; J Kolman; M Konkoly-Thege; J Miciuleviciene; M Pana; L Setchanova; J Trupl; P Urbaskova
Journal: Clin Microbiol Infect Date: 2003-07 Impact factor: 8.067

9. Emergence of macrolide resistance in throat culture isolates of group a streptococci in Ontario, Canada, in 2001.

Authors: Kevin C Katz; Allison J McGeer; Carla L Duncan; Aisha Ashi-Sulaiman; Barbara M Willey; Alicia Sarabia; Jacquie McCann; Sylvia Pong-Porter; Yana Rzayev; Joyce S de Azavedo; Donald E Low
Journal: Antimicrob Agents Chemother Date: 2003-07 Impact factor: 5.191

10. Erythromycin resistance in Streptococcus pyogenes in Italy.

Authors: M Bassetti; G Manno; A Collidà; A Ferrando; G Gatti; E Ugolotti; M Cruciani; D Bassetti
Journal: Emerg Infect Dis Date: 2000 Mar-Apr Impact factor: 6.883

22 in total

1. Rapid inversion of the prevalences of macrolide resistance phenotypes paralleled by a diversification of T and emm types among Streptococcus pyogenes in Portugal.

Authors: C Silva-Costa; M Ramirez; J Melo-Cristino
Journal: Antimicrob Agents Chemother Date: 2005-05 Impact factor: 5.191

2. Association between resistance to erythromycin and the presence of the fibronectin binding protein F1 gene, prtF1, in Streptococcus pyogenes isolates from German pediatric patients.

Authors: Maria Haller; Kirsten Fluegge; Sandra Jasminder Arri; Brit Adams; Reinhard Berner
Journal: Antimicrob Agents Chemother Date: 2005-07 Impact factor: 5.191

3. Resistance to erythromycin and telithromycin in Streptococcus pyogenes isolates obtained between 1999 and 2002 from Greek children with tonsillopharyngitis: phenotypic and genotypic analysis.

Authors: Ioanna N Grivea; Adnan Al-Lahham; George D Katopodis; George A Syrogiannopoulos; Ralf René Reinert
Journal: Antimicrob Agents Chemother Date: 2006-01 Impact factor: 5.191

4. Macrolide and tetracycline resistance and emm type distribution of Streptococcus pyogenes isolates recovered from Turkish patients.

Authors: Devrim Dundar; Murat Sayan; Gulden Sonmez Tamer
Journal: Microb Drug Resist Date: 2010-07-12 Impact factor: 3.431

5. Phenotypic and genotypic characterization of Streptococcus pyogenes isolates displaying the MLSB phenotype of macrolide resistance in Spain, 1999 to 2005.

Authors: Emilio Pérez-Trallero; Milagrosa Montes; Beatriz Orden; Esther Tamayo; José M García-Arenzana; José M Marimón
Journal: Antimicrob Agents Chemother Date: 2007-01-22 Impact factor: 5.191

Review 6. The use of macrolides in treatment of upper respiratory tract infections.

Authors: Aleksandra K Wierzbowski; Daryl J Hoban; Tamiko Hisanaga; Mel DeCorby; George G Zhanel
Journal: Curr Allergy Asthma Rep Date: 2006-03 Impact factor: 4.806

7. Identification of group A streptococcal emm types commonly associated with invasive infections and antimicrobial resistance by the use of multiplex PCR and high-resolution melting analysis.

Authors: P Bidet; S Liguori; C Plainvert; S Bonacorsi; C Courroux; C d'Humières; C Poyart; A Efstratiou; E Bingen
Journal: Eur J Clin Microbiol Infect Dis Date: 2012-05-20 Impact factor: 3.267